Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two laser wavelengths for treating varicose veins

Official title: Randomized Comparative Study With Two Wavelengths 1470 nm and 1940 nm for the Treatment of Varicose Veins of the Lower Limbs by Endovenous Laser.

Run by Clinique Pasteur · NCT05663359 · Data updated 2026-11-12

This study is testing whether using two different laser wavelengths to treat varicose veins can help patients feel better and have fewer complications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment280 (estimated)
SponsorClinique Pasteur
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedFebruary 24, 2023
Main results expectedFebruary 2032
Study endsFebruary 2032
Registry record updatedMarch 6, 2026
Trial IDNCT05663359 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with primary insufficiency of the great saphenous vein or small saphenous vein, with a vein diameter of 3 mm or greater.

Probably not a fit

Patients with serious underlying health conditions, recent vein thrombosis, or specific vascular issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of two different wavelengths (1940 nm and 1470 nm) used in Endovenous Laser Ablation (EVLA) for treating varicose veins in the lower limbs. The study will assess whether the higher wavelength improves treatment efficacy and reduces complications or pain compared to the lower wavelength. Participants will undergo laser ablation and will be monitored for five years to evaluate clinical outcomes, potential complications, and quality of life. The trial will involve patients with primary insufficiency of the great or small saphenous veins who meet specific inclusion criteria.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients with varicose veins, potentially enhancing efficacy and reducing complications.

How similar studies have gone: While there have been studies on EVLA, this specific comparison of wavelengths is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary insufficiency of the great saphenous vein (GSV) and/or small saphenous vein (SSV)
* Patient candidate for endothermic treatment of the lower limbs
* CEAP: C2 - C6
* Patient with a target vein diameter (GSV and/or SSV) \>= 3 mm throughout the target vein segment
* Patient affiliated or beneficiary of a social security scheme
* Patient having signed the informed consent

Exclusion Criteria:

* Patient with a current serious pathology and/or a life expectancy of less than 5 years
* Patient who has had a deep or superficial vein thrombosis in the previous 6 months
* Obliterating arteriopathy of the lower limb concerned, with an IPS \< 0.8 or \> 1.3
* Patient with post-thrombotic obstructive syndrome at the popliteal and/or femoral and/or iliac stage on the ipsilateral lower limb
* Patient with primary or post-thrombotic axial deep venous reflux on the ipsilateral lower limb
* Suspicion of non-post-thrombotic iliac compression on echo-doppler
* Contraindication to the planned treatment technique
* Patient whose geographical distance is not compatible with the follow-up of the study
* Pregnant or breastfeeding women
* Patient linguistically or psychologically unable to understand the information given, to give informed consent or to answer the study questionnaires.
* Protected patients: Adults under guardianship, or other legal protection; Hospitalized without consent.

Where it's running

  • Clinique Pasteur
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.